Results 21 to 30 of about 1,969,162 (302)

N prescriptions by drug class.

open access: yes, 2022
N prescriptions by drug class.
Zafer Keser (8722890)   +3 more
core   +1 more source

Assessment of Potentially Nephrotoxic Drug Prescriptions in Chronic Kidney Disease Outpatients at a Hospital in Indonesia. [PDF]

open access: yesInt J Nephrol Renovasc Dis
Larasati Arrum Kusumawardani,1,2 Hindun Wilda Risni,1,2 Darisa Naurahhanan,1 Syed Azhar Syed Sulaiman3 1Faculty of Pharmacy, Universitas Indonesia, Depok, Indonesia; 2Pharmacy Unit, Universitas Indonesia Hospital, Depok, Indonesia; 3School of ...
Kusumawardani LA   +3 more
europepmc   +2 more sources

Analysis of of medication and potential interactions in prescriptions containing antimicrobials distributed in a community pharmacy in the city of Ijuí /RS

open access: yesRevista de Epidemiologia e Controle de Infecção, 2012
Rationale and Objectives: Bacterial resistance is a worldwide concern and the inappropriate prescription of antimicrobials is one of the factors that can infl uence its rates.
Bruna Rodrigues Weber   +3 more
doaj   +1 more source

Characteristics of Outpatient Prescriptions for Frail Taiwanese Elders with Long-Term Care Needs

open access: yes, 2011
Objective To describe medication prescription patterns and associated factors among frail Taiwanese elders with long- term care needs defined as having physical or cognitive functioning impairments.
CHAN, DING-CHENG;HAO, YI-TING;WU, SHWU-CHONG   +1 more
core   +1 more source

Evaluation of the Prescription Pattern of Drugs Used in Treatment of Pelvic Inflammatory Disease at a Tertiary Care Hospital in Pune: A Cross-sectional Study

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Pelvic Inflammatory Disease (PID) is an inflammation of female upper genital tract which includes inflammation of uterine endometrium, fallopian tubes, ovaries and peritoneum.
Abhijit V Tilak   +5 more
doaj   +1 more source

Drug-drug interactions in repeat prescriptions at village dispensaries (bereg) in Malta [PDF]

open access: yes, 2013
Inappropriate treatments and drug-drug interactions (DDIs) are known to occur in settings where repeat prescriptions are issued. In view of this, a study was carried out to document any such problematic drug prescribing and propose changes that would
Bugeja, Anton
core  

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

Correction for potentially inappropriate prescribing can increase specificity when using drug prescriptions as an adjunct to diagnostic codes to assess comorbidities in older patients

open access: yesEpidemiology, Biostatistics and Public Health, 2019
Background: Comorbidities are a growing problem in older patients in many clinical settings, but electronic records may give an unsatisfactory picture of this complexity.
Gianfrancesco Fiorini   +5 more
doaj   +1 more source

The processes of reform in Victoria’s alcohol and other drug sector, 2011-2014 [PDF]

open access: yes, 2014
This paper explores issues and concerns related to the 2014 alcohol and other drug sector recommissioning process in Victoria. Overview In mid-2014, the Victorian Alcohol and Drug Association approached the Drug Policy Modelling Program, at the ...
Drug Policy Modelling Program
core  

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy